HEALTH POLICY RESEARCH ANALYST | PRINCETON SCHOOL OF PUBLIC AND INTERNATIONAL AFFAIRS, PRINCETON UNIVERSITY
Tsung-Mei Cheng is a health policy research analyst at the Princeton School of Public and International Affairs, Princeton University. Ms. Cheng’s current research focuses on cross-national comparisons of health systems in the United States, Europe and East Asia; health reforms in the U.S., China and Taiwan; health technology assessment and comparative effectiveness research; health care quality, financing and payment reform, including evidence based clinical guidelines and clinical pathways and pay for performance in East Asian health systems. She is co-founder, with Princeton economist Uwe Reinhardt, of the Princeton Conference, an annual national conference on health policy that brings together government, the private sector and the research community on issues affecting health care and health policy in the United States.
Ms. Cheng serves on the editorial board of Health Affairs, the leading health policy journal in the United States. She also serves as an advisor to the China National Health Development Research Center (CNHDRC), the official Chinese government think tank for health policy under China’s National Health Commission, formerly the Ministry of Health. She also serves as a special advisor to the Center for the Study of Major Policies (CSMP) of Tsinghua University. The Center focuses on translating research into policy and policy recommendations on major issues for high-level Chinese government.
Ms. Cheng served as an advisor to the National Institute for Health and Care Excellence International (NICE International) of the United Kingdom, which advises governments and agencies overseas on capacity building for evidence-based informing of national health policy as well as knowledge transfer among decision-makers across national borders. She also served as an advisor to the strategic review board of the Science and Technology Advisory Group (STAG), which advised the Office of the Premier of Taiwan, Republic of China, on policies relating to the development of science and technology including health care in Taiwan. Ms. Cheng also served as a member of the steering committee of the Emerging Market Symposium (EMS), a University of Oxford based initiative addressing pressing sectoral issues facing emerging market countries.
Ms. Cheng served on the international advisory board of the Elsevier On-line Encyclopedia of Health Economics, the online publication by the publisher of medical and scientific literature (The Lancet, Cell, Gray’s Anatomy, ScienceDirect, etc.) designed to meet the needs of the rapidly changing and growing field of health economics, which calls for timely “authoritative articles on key concepts, issues, theory and methods” in health economics. She also served on the technical advisory committee of the Global Task Force on Expanded Access to Cancer Care and Control (GTF.CCC), an initiative convened by the Harvard Global Equity Initiative, the Harvard Medical School, the Harvard T.H. Chan School of Public Health and the Dana Farber Cancer Institute to combat cancer in developing countries. Ms. Cheng was a member of the international advisory group of AcademyHealth, the U.S. based professional association of health services researchers.